265 related articles for article (PubMed ID: 36749262)
21. Cystic neoplasia of the pancreas: pathology and biology.
Adsay NV
J Gastrointest Surg; 2008 Mar; 12(3):401-4. PubMed ID: 17957438
[TBL] [Abstract][Full Text] [Related]
22. Not all mixed-type intraductal papillary mucinous neoplasms behave like main-duct lesions: implications of minimal involvement of the main pancreatic duct.
Sahora K; Fernández-del Castillo C; Dong F; Marchegiani G; Thayer SP; Ferrone CR; Sahani DV; Brugge WR; Warshaw AL; Lillemoe KD; Mino-Kenudson M
Surgery; 2014 Sep; 156(3):611-21. PubMed ID: 25081232
[TBL] [Abstract][Full Text] [Related]
23. Threshold of main pancreatic duct for malignancy in intraductal papillary mucinous neoplasm at head-neck and body-tail.
Zhou H; Li X; Wang Y; Wang Z; Zhu J; Wang Z; Chen X
BMC Gastroenterol; 2022 Nov; 22(1):473. PubMed ID: 36402960
[TBL] [Abstract][Full Text] [Related]
24. Prediction of malignancy in main duct or mixed-type intraductal papillary mucinous neoplasms of the pancreas.
Jung HS; Han Y; Kang JS; Sohn H; Lee M; Lee KB; Kim H; Kwon W; Jang JY
J Hepatobiliary Pancreat Sci; 2022 Sep; 29(9):1014-1024. PubMed ID: 35451206
[TBL] [Abstract][Full Text] [Related]
25. Correlation between CT patterns and pathological classification of intraductal papillary mucinous neoplasm.
Zhang J; Wang PJ; Yuan XD
Eur J Radiol; 2010 Jan; 73(1):96-101. PubMed ID: 19008065
[TBL] [Abstract][Full Text] [Related]
26. Nonoperative management of main pancreatic duct-involved intraductal papillary mucinous neoplasm might be indicated in select patients.
Roch AM; DeWitt JM; Al-Haddad MA; Schmidt CM; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
J Am Coll Surg; 2014 Jul; 219(1):122-9. PubMed ID: 24862887
[TBL] [Abstract][Full Text] [Related]
27. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules.
Sadakari Y; Ienaga J; Kobayashi K; Miyasaka Y; Takahata S; Nakamura M; Mizumoto K; Tanaka M
Pancreas; 2010 Mar; 39(2):232-6. PubMed ID: 19752768
[TBL] [Abstract][Full Text] [Related]
28. Serous cystadenoma in communication with the pancreatic duct: an unusual radiologic and pathologic entity.
Berman L; Mitchell KA; Israel G; Salem RR
J Clin Gastroenterol; 2010 Jul; 44(6):e133-5. PubMed ID: 20216080
[TBL] [Abstract][Full Text] [Related]
29. MRI findings of intraductal papillary mucinous neoplasms (IPMNs).
Lana S; Vallara M; Bono NE; Russo G; Artioli G; Capretti G; Paladini I; Pesce A; Ruggirello M; Barbalace S; Mostardi M
Acta Biomed; 2016 Jul; 87 Suppl 3():28-33. PubMed ID: 27467864
[TBL] [Abstract][Full Text] [Related]
30. The long term risk of malignancy in patients with branch duct intraductal papillary mucinous neoplasms of the pancreas.
Khannoussi W; Vullierme MP; Rebours V; Maire F; Hentic O; Aubert A; Sauvanet A; Dokmak S; Couvelard A; Hammel P; Ruszniewski P; Lévy P
Pancreatology; 2012; 12(3):198-202. PubMed ID: 22687372
[TBL] [Abstract][Full Text] [Related]
31. Risk of malignancy in resected cystic tumors of the pancreas < or =3 cm in size: is it safe to observe asymptomatic patients? A multi-institutional report.
Lee CJ; Scheiman J; Anderson MA; Hines OJ; Reber HA; Farrell J; Kochman ML; Foley PJ; Drebin J; Oh YS; Ginsberg G; Ahmad N; Merchant NB; Isbell J; Parikh AA; Stokes JB; Bauer T; Adams RB; Simeone DM
J Gastrointest Surg; 2008 Feb; 12(2):234-42. PubMed ID: 18040749
[TBL] [Abstract][Full Text] [Related]
32. Branch-duct intraductal papillary mucinous neoplasm (IPMN): Are cyst volumetry and other novel imaging features able to improve malignancy prediction compared to well-established resection criteria?
Pozzi Mucelli RM; Moro CF; Del Chiaro M; Valente R; Blomqvist L; Papanikolaou N; Löhr JM; Kartalis N
Eur Radiol; 2022 Aug; 32(8):5144-5155. PubMed ID: 35275259
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic Cystic Tumors: A Single-Center Observational Study.
Jabłońska B; Gudz A; Hinborch T; Bujała B; Biskup K; Mrowiec S
Medicina (Kaunas); 2023 Jan; 59(2):. PubMed ID: 36837443
[No Abstract] [Full Text] [Related]
34. Clinical Outcomes of Intraductal Papillary Mucinous Neoplasms With Dilatation of the Main Pancreatic Duct.
Hamada T; Oyama H; Nakai Y; Tange S; Arita J; Hakuta R; Ijichi H; Ishigaki K; Kanai S; Kawaguchi Y; Kogure H; Mizuno S; Saito K; Saito T; Sato T; Suzuki T; Takahara N; Tanaka M; Tateishi K; Ushiku T; Hasegawa K; Fujishiro M
Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1792-1801.e3. PubMed ID: 36787835
[TBL] [Abstract][Full Text] [Related]
35. Can the location of the mural nodule indicate benign or malignant in branch duct-type intraductal papillary mucinous neoplasm of the pancreas?
Niiya F; Ohike N; Norose T; Takano Y; Azami T; Kobayashi T; Maruoka N; Wakabayashi T; Matsuo K; Tanaka K; Nagahama M
Pancreatology; 2020 Oct; 20(7):1379-1385. PubMed ID: 32873485
[TBL] [Abstract][Full Text] [Related]
36. Cyst fluid SPINK1 may help to differentiate benign and potentially malignant cystic pancreatic lesions.
Räty S; Sand J; Laukkarinen J; Vasama K; Bassi C; Salvia R; Nordback I
Pancreatology; 2013; 13(5):530-3. PubMed ID: 24075519
[TBL] [Abstract][Full Text] [Related]
37. A Case of Serous Cystadenoma Communicating with a Stenotic Santorini's Duct and a Dilated Main Pancreatic Duct.
Matsubayashi H; Oka Y; Ito T; Uesaka K; Sasaki K; Ono H
J Gastrointestin Liver Dis; 2016 Dec; 25(4):551-554. PubMed ID: 27981313
[TBL] [Abstract][Full Text] [Related]
38. Main duct and mixed type intraductal papillary mucinous neoplasms without enhancing mural nodules: Duct diameter of less than 10 mm and segmental dilatation of main pancreatic duct are findings support surveillance rather than immediate surgery.
Kim TH; Song TJ; Lee SO; Park CH; Moon JH; Pih GY; Oh DW; Woo SM; Yang YJ; Kim MH
Pancreatology; 2019 Dec; 19(8):1054-1060. PubMed ID: 31611130
[TBL] [Abstract][Full Text] [Related]
39. Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis.
Crippa S; Bassi C; Salvia R; Malleo G; Marchegiani G; Rebours V; Levy P; Partelli S; Suleiman SL; Banks PA; Ahmed N; Chari ST; Fernández-Del Castillo C; Falconi M
Gut; 2017 Mar; 66(3):495-506. PubMed ID: 26743012
[TBL] [Abstract][Full Text] [Related]
40. Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions.
Das KK; Geng X; Brown JW; Morales-Oyarvide V; Huynh T; Pergolini I; Pitman MB; Ferrone C; Al Efishat M; Haviland D; Thompson E; Wolfgang C; Lennon AM; Allen P; Lillemoe KD; Fields RC; Hawkins WG; Liu J; Castillo CF; Das KM; Mino-Kenudson M
Gastroenterology; 2019 Sep; 157(3):720-730.e2. PubMed ID: 31175863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
